A MAGE-A1 peptide presented to cytolytic T lymphocytes by both HLA-B35 and HLA-A1 molecules

Tissue Antigens

Volumn 56, Issue 1, 2000, Pages 77-81

  Luiten, R M ^a,b   Demotte, N ^a   Tine, J ^c   Van Der Bruggen, Pierre ^a  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Belgium)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

^c Virogenetics Corporation   (United States)

Author keywords

CTL; HLA A1; HLA B35; MAGE; Peptide; Tumor

Indexed keywords

HLA A1 ANTIGEN; HLA B35 ANTIGEN; MELANOMA ANTIGEN; PEPTIDE;

AMINO ACID SEQUENCE; ANIMAL CELL; ANTIGEN PRESENTATION; ANTIGEN SPECIFICITY; ARTICLE; CANCER IMMUNOTHERAPY; CAUCASIAN; CONTROLLED STUDY; CYTOLYSIS; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; IMMUNOGENETICS; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; VACCINATION;

ANIMALS; ANTIGEN PRESENTATION; COS CELLS; CYTOTOXICITY TESTS, IMMUNOLOGIC; HLA-A1 ANTIGEN; HLA-B35 ANTIGEN; HUMANS; MELANOMA; NEOPLASM PROTEINS; PEPTIDES; T-LYMPHOCYTES, CYTOTOXIC; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0033927249     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0039.2000.560110.x     Document Type: Article

References (21)

1. 1. Van den Eynde B, Hainaut P, Hérin M et al. Presence on a human melanoma of multiple antigens recognized by autologous CTL. Int J Cancer 1989: 44: 634-40.
2. 2. van der Bruggen P, Traversari C, Chomez P et al. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 1991: 254: 1643-7.
3. 3. De Plaen E, Arden K, Traversari C et al. Structure, chromosomal localization and expression of twelve genes of the MAGE family. Immunogenetics 1994: 40: 360-9.
4. 4. Muscatelli F, Walker AP, De Plaen E, Stafford AN, Monaco AP. Isolation and characterization of a new MAGE gene family in the Xp21.3 region. Proc Natl Acad Sci U S A 1995: 92: 4987-91.
5. 5. Lurquin C, De Smet C, Brasseur F et al. Two members of the human MAGEB gene family located in Xp.21.3 are expressed in tumors of various histological origins. Genomics 1997: 46: 397-408.
6. 6. Lucas S, De Smet C, Arden KC et al. Identification of a new MAGE gene with tumor-specific expression by representational difference analysis. Cancer Res 1998: 58: 743-52.
7. 7. Takahashi K, Shichijo S, Noguchi M, Hirohata M, Itoh K. Identification of MAGE-1 and MAGE-4 proteins in spermatogonia and primary spermatocytes of testis. Cancer Res 1995: 55: 3478-82.
8. 8. Haas GG Jr., D'Cruz OJ, De Bault LE. Distribution of human leukocyte antigen-ABC and -D/DR antigens in the unfixed human testis. Am J Reprod Immunol Microbiol 1988: 18: 47-51.
9. 9. Pold M, Zhou J, Chen GL, Hall JM, Vescio RA, Berenson JR. Identification of a new unorthodox member of the MAGE gene family. Genomics 1999: 59: 161-7.
10. 10. Lucas S, Brasseur F, Boon T. A new MAGE gene with ubiquitous expression does not code for known MAGE antigens recognized by T cells. Cancer Res 1999: 59: 4100-3.
11. 11. Van den Eynde B, van der Bruggen P. T cell-defined tumor antigens. Curr Opin Immunol 1997: 9: 684-93.
12. 12. van Baren N, Brasseur F, Godelaine D et al. Genes encoding tumor-specific antigens are expressed in human myeloma cells. Blood 1999: 94: 1156-64.
13. 13. Traversari C, van der Bruggen P, Luescher IF et al. A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E. J Exp Med 1992: 176: 1453-7.
14. 14. Tanzarella S, Russo V, Lionello I et al. Identification of a promiscuous T cell epitope encoded by multiple members of the MAGE family. Cancer Res 1999: 59: 2668-74.
15. 15. van der Bruggen P, Szikora J-P, Boël P et al. Autologous cytolytic T lymphocytes recognize a MAGE-1 nonapeptide on melanomas expressing HLA-Cw*1601. Eur J Immunol 1994: 24: 2134-40.
16. 16. Fujie T, Tahara K, Tanaka F, Mori M, Takesako K, Akiyoshi T. A MAGE-1-encoded HLA-A24-binding synthetic peptide induces specific anti-tumor cytotoxic T lymphocytes. Int J Cancer 1999: 80: 169-72.
17. 17. Chaux P, Luiten R, Demotte N et al. Identification of five MAGE-A1 epitopes recognized by cytolytic T lymphocytes obtained by in vitro stimulation with dendritic cells transduced wit MAGE-A1. J Immunol 1999: 163: 2928-36.
18. 18. Luiten R, van der Bruggen P. A MAGE-A1 peptide is recognized on HLA-B7 human tumors by cytolytic T lymphocytes. Tissue Antigens 2000: 55: 149-52.
19. 19. Cornelis GR. The Yersinia deadly kiss. J Bacteriol 1998: 180: 5495-504.
20. 20. Marsh SGE, Parham P, Barber LD. The HLA factsbook. London: Academic Press, 2000.
21. 21. Rammensee H-G, Bachmann J, Stevanovic S. MHC ligands and peptide motifs. Heidelberg: Springer, 1997.